Chardonnet Laurent Insider Trades

Insider Trading History

Track insider trading activity for Chardonnet Laurent. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Financial Officer
Holding Value $612k 150,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$689k 150,000 shares
$4.59
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Financial Officer
Holding Value $172k 42,165 shares
Last Trade
May 23, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.5k 5,000 shares
$5.50
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Financial Officer
Holding Value $551k 135,000 shares
Last Trade
Feb 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$972k 135,000 shares
$7.20
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Director, Chief Financial Officer
Holding Value $306k 75,000 shares
Last Trade
Dec 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$368k 75,000 shares
$4.90
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Director, Chief Financial Officer
Holding Value $146k 35,873 shares
Last Trade
Dec 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$47.6k 10,000 shares
$4.76
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Director, Chief Financial Officer
Holding Value $100k 24,500 shares
Last Trade
Jun 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.3k 10,000 shares
$4.23
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Financial Officer
Holding Value $59.2k 14,500 shares
Last Trade
Mar 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.8k 6,500 shares
$7.51
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Financial Officer
Holding Value $367k 90,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$952k 90,000 shares
$10.58
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Financial Officer
Holding Value $32.6k 8,000 shares
Last Trade
Dec 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.4k 5,000 shares
$12.28
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Financial Officer
Holding Value $734k 180,000 shares
Last Trade
Nov 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.48M 180,000 shares
$13.75
$4.08
Axcella Health
Axcella Health AXLA
Chief Financial Officer
Holding Value $550k 120,000 shares
Last Trade
Feb 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$876k 145,000 shares
$6.04
$4.58
Axcella Health
Axcella Health AXLA
Chief Financial Officer
Holding Value $28.7k 6,266 shares
Last Trade
Oct 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11k 2,601 shares
$4.24
$4.58
Axcella Health
Axcella Health AXLA
Chief Financial Officer
Holding Value $16.8k 3,665 shares
Last Trade
Jan 31, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.8k 3,000 shares
$4.94
$4.58
Axcella Health
Axcella Health AXLA
Chief Financial Officer
Holding Value $3.05k 665 shares
Last Trade
Jan 27, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.74k 352 shares
$4.94
$4.58
Axcella Health
Axcella Health AXLA
Chief Financial Officer
Holding Value $1.43k 313 shares
Last Trade
Jan 24, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.54k 313 shares
$4.92
$4.58
Axcella Health
Axcella Health AXLA
Chief Financial Officer
Holding Value $332k 72,500 shares
Last Trade
Dec 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$247k 72,500 shares
$3.40
$4.58
Incyte
Incyte INCY
other, Vice President And Treasurer
Holding Value $7.16M 70,681 shares
Last Trade
Mar 30, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.7M 113,776 shares
$93.64
$101.24
Incyte
Incyte INCY
other, Vice President And Treasurer
Holding Value $680k 6,717 shares
Last Trade
Mar 30, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.7M 113,776 shares
$94.19
$101.24
Incyte
Incyte INCY
other, Vice President And Treasurer
Holding Value $11.8M 116,681 shares
Last Trade
Mar 30, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.7M 113,776 shares
$94.19
$101.24
Incyte
Incyte INCY
other, Vice President And Treasurer
Holding Value $690k 6,818 shares
Last Trade
Jan 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 15,136 shares
$67.63
$101.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up